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ABSTRACT
Protein p6 of Bacillus subtilis bacteriophage F29 is
essential for phage development. In vitro it activates
the initiation of DNA replication and is involved in
the early to late transcriptional switch. These activ-
ities require the formation of a nucleoprotein com-
plex in which the DNA forms a right-handed
superhelix wrapping around a multimeric protein
core. However, there was no evidence of p6 binding
to F29 DNA in vivo. By crosslinking, chromatin
immunoprecipitation and real-time PCR we show
that protein p6 binds to most, if not all, the viral
genome in vivo, although with higher af®nity for
both DNA ends, which contain the replication
origins. In contrast, the af®nity for plasmid DNA is
negligible, but greatly increases when the negative
supercoiling decreases, as shown in vivo by treat-
ment of cells with novobiocin and in vitro by ¯uor-
escence quenching with plasmids with different
topology. In conclusion, binding of protein p6 all
along the F29 genome strongly suggests that its
functions in replication and transcription control
could be local outcomes of a more global role as a
histone-like protein. The p6 binding dependence on
DNA topology could explain its preferential binding
to viral with respect to bacterial DNA, whose level of
negative supercoiling is presumably higher than
that of F29 DNA.
INTRODUCTION
In living cells, genomes are packed and organized by
architectural proteins associated with DNA. Randomly folded
naked DNA would occupy a much larger volume than that of
the nuclear compartment or the bacterial cell. Besides, such
DNA would be unable to correctly perform essential functions
such as replication, transcription, recombination, repair,
segregation, mitosis or meiosis. These processes require the
interaction of proteins that modify the conformation of DNA
by inducing compaction, bending and/or supercoiling.
In Eukarya the main architectural proteins are histones,
which compact and scaffold chromosomes into a chromatin
®ber formed by nucleosomes. Histones drive structural
changes in chromatin to regulate the accessibility and
transcriptional state of genes (for a review see 1). Other
non-histone, sequence-unspeci®c DNA-binding proteins, such
as HMG, also participate in structuring the DNA by competing
with and modulating histone binding and by inducing
curvature and distortions in DNA (for a review see 2).
Condensins and cohesins are members of the SMC proteins, a
family of chromosomal ATPases that play central roles in
chromosome condensation and sister chromatid cohesion,
respectively (for a review see 3). As puri®ed mitotic 13S
condensin induces positive supercoiling in plasmid DNA, it is
believed that condensin regularly supercoils interphase
chromatin by affecting global writhe (4).
In Eubacteria the DNA architectural role has been allotted
to the so-called histone-like proteins (for reviews see 5,6).
These proteins are mostly sequence-non-speci®c and are
proposed to distribute along the entire nucleoid, as shown
mainly by ¯uorescence approaches (7±9). In Escherichia coli
the most abundant ones are HU, Fis, H-NS, IHF, Dps and StpA
(10). In Bacillus subtilis it has been proposed that other
proteins such as HBsu (7) and L24 (11) organize the nucleoid
in vivo or play a local architectural role like LrpC (12,13). A
single SMC protein is also found in B.subtilis, but not in
E.coli, which however contains a protein, MukB, with a
similar structure. Like their eukaryotic counterparts, both
SMC and MukB are essential for chromosome condensation,
supercoiling and correct partitioning (for a review see 14).
B.subtilis phage F29 protein p6 is small (103 amino acids)
(15) and very abundant, at ~700 000 copies/infected cell, 1.4
times the amount necessary to cover all the F29 DNA
molecules present at mid-infection times (16). Comparatively,
the most abundant histone-like protein of E.coli, Dps, reaches
180 000 copies/cell in late stationary phase, and HU 60 000
copies/cell (10); in B.subtilis, HBsu attains 50 000 copies/cell,
only 0.2-fold the amount necessary to bind the full F29 DNA
(17). In vitro protein p6 binds DNA without sequence
speci®city (18,19), restraining positive supercoils on a
covalently closed DNA, similarly to condensins, involved in
the high order compaction of DNA needed for the formation of
mitotic chromosomes (20). A model has been proposed for
the p6±DNA nucleoprotein complex, in which the DNA is
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right-handedly wrapped around a multimeric core of protein
p6, therefore restraining positive supercoiling (21), with a DLk
of +0.1 per single protein p6 dimer (18). Finally, protein p6
has a pleiotropic effect, participating in viral DNA replication
and transcription control. In vitro p6 binds to F29 DNA
termini to enhance the initiation of DNA replication (22) from
the origins located at both DNA ends and to repress
transcription from the early promoter C2 at the right DNA
end (23±25). Protein p6 also binds to the central transcription
control region where, together with the viral transcription
regulator p4, it triggers the switch of in vitro transcription
from the main early promoters A2b and A2c to the late
promoter A3 (26±28). However, and in spite of all the wealth
of in vitro data, there was no in vivo evidence of p6 binding to
DNA.
Consequently, to determine whether protein p6 indeed
binds F29 DNA in vivo and, if so, to test its binding
speci®city, we used formaldehyde-crosslinked chromatin
immunoprecipitation (X-ChIP) (29,30). This powerful tech-
nique has allowed mapping of the in vivo DNA-binding sites
of diverse proteins of many organisms (for a review see 31),
including such B.subtilis proteins as SMC (9). To obtain
quantitative data on protein p6 binding af®nities for different
DNA regions we combined the X-ChIP approach with real-
time PCR.
In this work we show that protein p6 is able to bind most, if
not all, the viral genome, strongly suggesting that its functions
in DNA replication and transcriptional control are local
outcomes of a more general role as an architectural protein.
We also show that binding to the viral DNA is much higher
than that to plasmid DNA. However, the af®nity for the latter
is enhanced when negative supercoiling is decreased, as
shown in vivo and in vitro. Protein p6 supercoiling-dependent
binding could be the basis for the preferential binding to F29
with respect to plasmid DNA.
MATERIALS AND METHODS
Bacteria, plasmids and phages
Bacillus subtilis 110NA (trpC2, spoOA3, su±) (32) containing
pUB110 derivatives pPR55w6 and pPR55ow6 (33) was used.
Figure 1 shows a map of these plasmids, which contain F29
gene 6 in either the correct (w6) or inverted (ow6) orientation.
Phage F29 sus 14 (1242), a delayed lysis mutant (34), was
used for all infections. Bacteria were grown in LB broth
supplemented with 5 mM MgSO4. Phleomycin (Cayla
S.A.R.L.) was added to the medium at a ®nal concentration
of 0.8 mg/ml. As a source of plasmid pL259, a BlueScript KS
Plus derivative (35), a strain of E.coli DH5a was used; in this
case, 10 mg/ml ampicillin was added to the medium.
Reagents
Micrococcal nuclease was from Amersham Pharmacia
Biotech and proteinase K from Boehringer Mannheim.
Wheatgerm topoisomerase I was acquired from Promega
and SpeI from New England Biolabs. Protein A±Sepharose
CL-4B, lysozyme, RNase A, ampicillin, chloramphenicol,
novobiocin, nalidixic acid and chloroquine were from Sigma.
Formaldehyde at 37% was purchased from Calbiochem.
DNAs and oligonucleotides
Proteinase K-digested F29 DNA was obtained as described
(36); plasmids pPR55ow6 and pL259, used for ¯uorescence
measurements, were puri®ed using a Promega Wizard Plus SV
miniprep kit. The sequences of the oligonucleotides used for
PCR (Isogen) and the coordinates of the ampli®ed DNA
sequences are depicted in Table 1.
Crosslinking, immunoprecipitation and DNA
ampli®cation
The X-ChIP was performed basically as described (37).
Analysis of DNA samples was performed by real-time PCR in
Figure 1. Map of plasmids pPR55w6 and pPR55ow6. These plasmids
(4.6 kb) contain F29 gene 6 under the control of the l PR promoter in
pPR55w6 or in the inverted orientation in pPR55ow6. Genes encoding the
replication protein repU and for phleomycin resistance (ble) are indicated.
The sequences selected for PCR ampli®cation are shown in black and the
protein p6-binding regions studied, P1 and P2, are shown in gray, as
explained in Figure 2B.
Table 1. Oligonucleotides used in this work
Region Coordinates Sequence
F1 U-1 5¢-AAAGTAAGCCCCCACCCTCACATG
L-259 5¢-GCCCACATACTTTGTTGATTGG
F2 U-4895 5¢-GATTTCTCTCTGCATCATTTTTGC
L-5257 5¢-CAAAATATCTTCGTGTTCTTCTGG
F3 U-7255 5¢-GAAGTAGATGATATTAAGGACGCC
L-7528 5¢-CTGACAGAAGACCAAGCACATCGG
F4 U-9507 5¢-CTGACAACATCGGAAATTACAGCG
L-9820 5¢-TTGTTGTAAACGTCTCTCTGACCC
F5 U-11567 5¢-GGATTCTCAATGACGGGTTAGA
L-11778 5¢-CACATACACAGGAAAACCAGACTC
F6 U-18988 5¢-AAATAGATTTTCTTTCTTGGCTAC
L-1928 5¢-AAAGTAGGGTACAGCGACAACATAC
P1 U-2578 5¢-GGGCACAAATCGCATCGTGGAACG
L-2873 5¢-TCTTGGTCGTCAGACTGATGGGCC
P2 U-155 5¢-GGGCACAAATCGCATCGTGGAACG
L-456 5¢-TCTTGGTCGTCAGACTGATGGGCC
Sequences of the primers used for ampli®cation of F29 (F1±F6) or
plasmid (P1 and P2) DNA sequences. The coordinates of the terminal 5¢
nucleotides are given, indicating whether they correspond to the upper (U)
or lower (L) strand.
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a Light-Cycler instrument using a Light Cycler-FastStart DNA
Master SYBR Green I hot-start reaction mix (Roche). Samples
corresponding to total, ap6-immunoprecipitated or preim-
mune serum (pi)-immunoprecipitated DNA were ampli®ed for
each DNA region using the primers depicted in Table 1. The
crossing points (the cycle at which ampli®cation enters the
exponential phase) were determined and data were inter-
polated to a standard curve constructed with known amounts
of puri®ed, full-length F29 or plasmid DNA. The raw data
were expressed as pg F29 or plasmid DNA per ml culture.
Protein p6 binding was expressed as the immunoprecipitation
coef®cient (IC), the quotient between the speci®cally
immunoprecipitated DNA (ap6 ± pi) and the total DNA
amount for a given region.
The ampli®cation conditions included a preheating step of
20 min at 95°C to activate the polymerase, followed by 30
cycles comprising a denaturation step of 15 s at 95°C for all
regions, a hybridization step of 5 s at 53°C for regions F1 and
F5, 5 s at 50°C for F6, 10 s at 51°C for F3 and F4, 10 s at
50°C for P1 and 10 s at 48°C for F2 and P2, and an elongation
step at 72°C lasting 15 s for F1 and F5, 30 s for F3 and F4,
40 s for F6 and P1 and 60 s for F2 and P2. Finally, a melting
analysis was performed by continuous ¯uorescence measure-
ment from 65 to 95°C, to ensure the presence of a single
speci®c ampli®cation product. Non-speci®c hybridization of
primers to bacterial DNA was previously ruled out in a control
with uninfected cells.
Topoisomer analysis
For the analysis of plasmid pPR55ow6 isolated from
novobiocin- or nalidixic acid-treated cells, ~1 mg puri®ed
plasmid was treated with 1 U topoisomerase I for 30 s at 30°C
in a buffer containing 50 mM Tris±HCl, pH 7.5, 50 mM NaCl,
0.1 mM EDTA, 1 mM dithiothreitol and 10 mM MgCl2.
Reactions were stopped by addition of SDS to 1% and samples
applied to a 1.2% agarose gel. Electrophoresis was run in 13
TBE buffer (90 mM Tris±borate and 2 mM EDTA) for 14 h at
35 V and 3 h at 100 V. The gel was soaked in 1 mg/ml
chloroquine for 4 h, rotated 90° and electrophoresed at 100 V
for 3 h. Finally, the gel was stained with ethidium bromide and
photographed with a UviDoc-008.XD apparatus. Image pro-
cessing and densitometry was performed with ImageQuant
software. The median of the topoisomer distribution was
calculated as described (38).
For the ¯uorescence measurements, stocks of plasmid
pL259 with different topoisomer distributions were obtained
by treatment for different times with 10 U topoisomerase I
and, where indicated, with protein p6 to induce positive
supercoiling. Samples were digested with proteinase K and
puri®ed by phenol extraction and ethanol precipitation.
Aliquots were taken and subjected to 2-dimensional agarose
gel electrophoresis as described above. The linearized form of
plasmid pL259 was obtained by digestion with SpeI.
Fluorescence measurements
Fluorescence measurements were performed in a Varian Cary
Eclipse spectro¯uorometer and monitored in a 2 mm path
length cell at a temperature of 15°C. The tryptophan residue of
protein p6 was excited at a wavelength of 290 nm and
¯uorescence measured at 350 nm.
The value of maximal quenching of ¯uorescence (Qmax =
0.84) upon DNA binding was determined by reverse titration
experiments in which increasing amounts of linearized
plasmid pL259 were added to a ®xed amount of protein p6.
The experiments were done in 50 mM Tris±HCl, pH 7.5,
10 mM MgCl2, at a protein p6 concentration of 1, 3, 7 and
12 mM to ensure that the point of complete saturation was
reached (39). The ¯uorescence emission constant (fA =
290/mM) of free protein p6 was determined by measuring
the ¯uorescence of increasing amounts of p6 in the absence of
DNA.
To determine the effective binding constant (Keff = Kw, w
being the cooperativity) of protein p6 to the different
topological forms of the plasmid, direct titration experiments
were performed (40,41). Protein p6 was added to plasmid
DNA (20 mM) in 50 mM Tris±HCl, pH 7.5, 10 mM MgCl2,
measuring ¯uorescence after mixing the sample by gentle
shaking and incubating for 30±60 s. To calculate Keff, we
carried out a ®tting procedure based on previously published
expressions (40) and on the theory of McGhee and von Hippel
(42) for the binding of proteins to polynucleotides. The ®tting
procedure was started by ®xing the values of Qmax, fA and the
binding site size of a protein p6 monomer (n = 12) (21) and
setting K and w as the ®tting parameters, and continued by an
iteration algorithm designed in our laboratory (43). We also
performed a graphical approximation to Keff as described (41).
In a plot of the saturation fraction versus [p6]free, assuming
that w >> n, the value of [p6]free corresponding to half
saturation yields 1/Kw (39,42).
RESULTS
Protein p6 binds preferentially to F29 DNA in vivo
To determine whether p6 binds F29 DNA in vivo we used the
X-ChIP technique. After treatment with formaldehyde DNA
was sonicated and immunoprecipitated with ap6 antibodies. A
control immunoprecipitation was performed in parallel with
preimmune serum. Selected sequences, 300 bp on average,
were ampli®ed and quanti®ed by real-time PCR. Protein p6
binding is expressed as IC, in which the value obtained with
preimmune (pi) serum was subtracted from that obtained with
ap6 serum and normalized to the total amount of DNA (T) of
that region {IC = [(ap6 ± pi)/T] 3 106}. ap6, pi and T values
were calculated by real-time PCR and expressed as pg
DNA/ml culture. Therefore, protein p6 binding to different
DNA regions of plasmid and viral DNA can be directly
compared, since it is not dependent on their amount in the cell
nor on their ampli®cation ef®ciency. Figure 2A indicates the
genomic position of the six F29 DNA regions analyzed,
scattered along the viral chromosome and termed F1±F6. As
illustrated in Figure 2B, these regions comprise not only the
ampli®ed sequence (~300 bp, black), but also ~450 additional
base pairs on each side (gray), as the average size of sonicated
DNA was ~750 bp. Regions F1 and F6 correspond to the left
and right F29 DNA ends, respectively, and contain the
replication origins; F6 also comprises the early promoter C2.
Region F2 includes the central transcriptional control region,
with the early promoters A2b and A2c and the late promoter
A3. Regions F3, F4 and F5 correspond to late genes.
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Figure 3 shows protein p6 binding to the six F29 DNA
regions, F1±F6, as well as to a region, termed P1, from
plasmid pPR55ow6, a pUB110 derivative (33), in F29-
infected B.subtilis cells. We measured protein p6 binding at 20
(Fig. 3A) and 35 (Fig. 3B) min post-infection. At 20 min the
p6/F29 DNA ratio is higher than at 35 min, since, as measured
by real-time PCR, DNA replication had just started
(M.Alcorlo, personal communication) and the intracellular
amount of protein p6 had not still leveled off (16). In contrast,
at 35 min the DNA concentration had increased more than that
of protein p6 and consequently the IC values were lower. At
both times we observed that protein p6 binds to all six F29
DNA regions studied, which are scattered and comprise ~30%
of the total F29 DNA (see Fig. 2A). The highest p6 binding
corresponds to regions F1 and F6 at both DNA ends, whereas
the af®nity for the internal regions is lower, especially for
region F2, which contains the transcription control region.
Finally, binding to plasmid DNA is signi®cantly lower than
that to any of the F29 DNA regions analyzed. This is
especially clear at 35 min, when the IC for P1 is 15-fold lower
than that for region F2, the lowest af®nity F29 DNA region.
As an additional control, immunoprecipitation was also
performed with antibodies against F29 protein p17, another
viral early protein that does not bind DNA in vitro and whose
intracellular concentration is close to that of protein p6 (44).
No protein p17 binding was detected for the F29 DNA regions
analyzed (not shown), therefore, the possibility that the results
are due to random protein±DNA collisions rather than to a
genuine interaction can be ruled out.
Protein p6 binding to plasmid DNA is enhanced by
decreasing negative supercoiling
In vitro experiments suggested that p6 restrains DNA positive
supercoiling (18), therefore we studied the effect of topology
on p6 binding to plasmid DNA. For these experiments we used
plasmids pPR55 w6/ow6 (see Fig. 1) and the gyrase inhibitors
novobiocin, which decreases negative supercoiling, and as a
control nalidixic acid, which does not change superhelicity
(45). Figure 4 shows the topoisomer distribution of plasmids
after novobiocin or nalidixic acid treatment, with the respect-
ive medians indicated by arrows. Thus, as expected, under our
in vivo conditions negative supercoiling of plasmid DNA is
clearly decreased by novobiocin, but essentially unchanged by
nalidixic acid.
Therefore, we studied protein p6 binding to plasmid DNA
in the absence or presence of novobiocin or nalidixic acid.
Cells hosting plasmid pPR55ow6 were infected with F29,
grown for an additional 20 min and then crosslinked after
addition or not of novobiocin or nalidixic acid. Uninfected
cells harboring plasmid pPR55w6, which express protein p6
Figure 2. Location of the F29 DNA regions analyzed for protein p6 binding. (A) Genetic map of the linear F29 DNA (19.3 kb). The positions of the genes,
numbered 1±17, are indicated; .5±.9 stands for 16.5±16.9 respectively. The 5¢-bound terminal protein is depicted as a black circle. The arrows point in the
direction of transcription: the early promoters C2, A2b and A2c transcribe leftwards and the late promoter A3 rightwards. The sequences selected for PCR
ampli®cation are shown in black and the regions studied for protein p6 binding, F1±F6, are shown in gray. (B) Detail of an average region studied for p6
binding. DNA is sheared by sonication to an average size of 750 bp. Each region would then comprise all the overlapping DNA fragments that contain the
ampli®ed sequence (black rectangles). According to the average size of the ampli®ed sequences (~300 bp) and that of the sonicated DNA fragments
(~750 bp), every DNA tract analyzed has ~1200 bp. This value would be only 750 bp for regions F1 and F6, as the ampli®ed sequences are located at the
ends of the linear DNA.
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constitutively, were also crosslinked in the absence or
presence of novobiocin and nalidixic acid as described.
Protein p6 binding, expressed as IC, was determined by real-
time PCR for region P1 of plasmid pPR55ow6 in F29-infected
cells (P1f) and for regions P1 and P2 of plasmid pPR55w6 in
protein p6-producing cells (P1p and P2p) (see Fig. 1). Figure 5
shows that addition of novobiocin results in a signi®cant
increase in protein p6 binding to plasmid DNA in both F29-
infected and uninfected cells. Binding to region P1 in F29-
infected cells (P1f) increased 23-fold (IC = 1645) and for
regions P1 and P2 in protein p6-producing uninfected cells
(P1p and P2p) the increases were 34- (IC = 4546) and 27-fold
(IC = 2780). In contrast, nalidixic acid, which does not change
DNA topology, produced only slight changes in protein p6
binding. The higher protein p6 binding to region P1 in p6-
producing cells with respect to infected cells could be due to
titration of p6 by F29 DNA. In summary, these results clearly
indicate that protein p6 binding to DNA is dependent on
superhelicity.
Supercoiling-dependent protein p6 binding to plasmid
DNA in vitro
We studied the effect of topology on p6 binding to plasmid
DNA in vitro. Protein p6 has a single tryptophan residue at
position 46 whose ¯uorescence is quenched upon DNA
binding. Therefore, we measured p6 binding by ¯uorescence
quenching with different topological forms of plasmid pL259,
which allows calculation of the respective binding constants of
protein p6. We also analyzed the linearized form of the
plasmid (L) as a control. Figure 6A shows the native form of
the plasmid, designated supercoiled form I (sc I), and the
topoisomer distributions of topoisomerase I-treated plasmids,
termed sc II, sc III and sc IV.
As a previous step, we calculated the maximal quenching
value (Qmax) of protein p6 by reverse titration experiments (as
described in 39), in which increasing amounts of the linearized
plasmid were added to a ®xed amount of protein p6,
measuring the maximal ¯uorescence quenching that was
reached. We assayed four concentrations of p6, 1, 3, 7 and
12 mM, ®nding an increase in the apparent Qmax from 0.60 at
1 mM p6 to 0.80 at 3 mM and 0.84 at 7 mM. This value of
0.84 remained constant at 12 mM p6.
To determine the Keff values for the different topological
forms of pL259 we performed direct titration experiments in
which increasing amounts of protein were added to a ®xed
amount of DNA (40,41), as described in Materials and
Methods. As shown in Figure 6B, in all cases the initial slope
of the curves decreased, indicating binding to DNA. The
turning point and the slope of the curves during the DNA
binding phase indicate different af®nities for protein p6, being
highest for the linear DNA and lowest for the sc I form. The
slopes of the curves of the sc II, sc III and sc IV forms are
proportional to their degree of negative supercoiling. When a
certain protein concentration is reached, the slope increases
parallel to that of the free protein. For the linear DNA sample
this is shown in Figure 6B as a dotted line. The point where
this line intercepts the abscissa corresponds to a protein
concentration [p6] = Qmax [DNA]/n (40). For the [DNA] used,
we obtained a value of Qmax/n = 0.072, which gives Qmax =
0.86 for n = 12, very close to that of 0.84 obtained by reverse
titration; for Qmax = 0.84, a value of n = 11.7 is obtained, close
to that of 12 obtained by footprinting (21). In the correspond-
ing lines for the supercoiled samples, the slope also increases
parallel to that of the free protein, but intercepts the abscissa at
a lower protein p6 concentration. In Figure 6B we show the
slope of sc I as a dashed line for which Qmax/n = 0.038, which
would give Qmax = 0.46 for n = 12 or n = 22 for Qmax = 0.84.
This signi®cant variation with respect to the values obtained
for the linear DNA would indicate that for a topologically
restricted DNA, saturation cannot be reached: as every protein
p6 molecule that binds restrains positive supercoiling (18) and
produces a compensatory negative supercoiling, this would
further impair the next molecule binding. Eventually, the
superhelical tension would prevent saturation of DNA by
protein p6. The amount of protein p6 allowed to bind DNA
would be inversely proportional to the degree of negative
supercoiling of the sample. The Keff values for p6 binding to
the DNA samples were calculated by computer ®tting of direct
Figure 3. Protein p6 binding to F29 and plasmid DNA. Cells harboring
plasmid pPR55ow6 (see Fig. 1) were infected, crosslinked 20 (A) or 35
(B) min later and processed as described in Materials and Methods. Protein
p6 binding to F29 and plasmid DNA regions (F1±F6 and P1, respectively)
is expressed as the immunoprecipitation coef®cient IC (see text).
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titrations ¯uorescence data as described in Materials and
Methods. They were found to be 6.7 3 105 for sc I, 1.0 3 106
for sc II, 1.4 3 106 for sc III, 1.7 3 106 for sc IV and 2.7 3 106
per M for the linear sample. Here it is not possible to
determine K and w independently due to the inability of
supercoiled samples to reach saturation, as explained above.
Figure 6C shows a plot of the saturation fraction (q) against
[p6]free in order to obtain a graphical estimation of Keff values,
de®ned as the reciprocal of [p6]free when 50% of the DNA is
bound to protein (41). The Keff values obtained, 7.5 3 105 for
sc I, 1.1 3 106 for sc II, 1.3 3 106 for sc III, 1.6 3 106 for sc IV
and 2.6 3 106 per M for the linear sample, are nearly identical
to those obtained from the ®t of direct titration data and
together con®rm the dependence of p6 binding on the
superhelical state of the DNA. Direct titrations were also
performed with linearized and supercoiled native pPR55ow6
plasmid, used in the in vivo studies, obtaining analogous
results (not shown).
In summary, these data demonstrate that p6 binding is
inversely proportional to the degree of negative supercoiling
of DNA, in agreement with the observed effect of novobiocin
in p6 binding to plasmid DNA in vivo and with the ability of
p6 to restrain positive supercoils in vitro (18). This super-
coiling-dependent binding most probably constitutes the basis
of the p6 speci®city for viral DNA observed in vivo, as the
non-covalently closed F29 DNA is presumably less nega-
tively supercoiled than the bacterial DNA.
DISCUSSION
Proteins involved in organization and compaction of chromo-
somes have been described in virtually every organism. These
architectural proteins share basic features such as abundance,
sequence-non-speci®city and pleiotropic effects, involved in
diverse DNA transactions. In bacteria these proteins are
commonly known as `histone-like' (5±6) and a number of
them have been co-localized in vivo with the nucleoid (7±9).
Figure 4. Effect of gyrase inhibitors on the linking number of plasmid DNA. Topoisomer distribution of plasmid DNA puri®ed from cells treated with
novobiocin or nalidixic acid. Cells harboring plasmid pPR55ow6 were grown up to108 cells/ml and 20 min later 500 mg/ml novobiocin or nalidixic acid were
added. Cells were harvested 10 min later and plasmid DNA was puri®ed and treated with topoisomerase I. Topoisomers were resolved by 2-dimensional
agarose gel electrophoresis as described in Materials and Methods. The asterisk indicates the position of nicked DNA. The arrows point to the position of the
most abundant topoisomer, determined by densitometry with ImageQuant software. Numbers indicate the median of the topoisomer distribution.
Figure 5. Protein p6 binding to plasmid DNA in the absence or presence of
novobiocin or nalidixic acid. Cells hosting plasmid pPR55ow6 were
infected with F29 and 20 min later split into three aliquots. One was
crosslinked without further treatment; the other two were treated with
either novobiocin or nalidixic acid (500 mg/ml each), together with
chloramphenicol (34 mg/ml). Under these conditions chloramphenicol
completely prevents expression of p6 (unpublished results). Cells were
crosslinked 10 min later. Uninfected cells harboring plasmid pPR55w6,
which expresses protein p6 constitutively at levels similar to those in
infected cells, were also crosslinked in the absence or presence of
novobiocin and nalidixic acid as described. Protein p6 binding, expressed as
IC (see text) was measured for region P1 of plasmid pPR55ow6 in
F29-infected cells (P1f) and for regions P1 and P2 of plasmid pPR55w6 in
protein p6-producing cells (P1p and P2p) (see Fig. 1).
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Using X-ChIP and real-time PCR we here provide direct
evidence that protein p6 of B.subtilis bacteriophage F29 binds
in vivo all along the viral genome in the manner of a
histone-like protein. We have studied p6 binding to six regions
of F29 DNA in vivo, scattered along and comprising ~30% of
the viral genome, demonstrating that protein p6 binds to all of
Figure 6. Analysis by ¯uorescence quenching of protein p6 binding in vitro to plasmids with different topology. (A) Topoisomer distribution of the samples
used for ¯uorescence studies. Plasmid pL259 was isolated from E.coli DH5a. The supercoiled form I (sc I), corresponds to the untreated plasmid, whereas sc
II and sc III are topoisomerase I-treated plasmid and sc IV topoisomerase I-treated plasmid in the presence of protein p6 to favor the production of positive
topoisomers. After puri®cation, ~1.5 mg was applied to a 1.2% agarose gel and subjected to 2-dimensional gel electrophoresis as described in Materials and
Methods. (B) Direct titration of 20 mM plasmid pL259. Fluorescence emission was measured after each addition of protein p6 and plotted against the protein
p6 concentration. L, linearized plasmid, sc I±sc IV as above. The ®nal asymptotic lines for the binding curves of linear (dotted) and sc I (dashed) samples are
shown and extrapolated to the abscissa. Data are from a single representative experiment performed at least three times. (C). The saturation fraction (q) is
plotted against the free protein p6 concentration, from the data shown in (B). The Keff values were estimated from these curves as the inverse of the [p6]free
when 50% of the DNA is bound to protein.
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them. This strongly suggests that protein p6 is likely to form
nucleoprotein complexes along most, if not all, the viral DNA.
However, binding to F29 DNA is not the same in all the
regions, but highest at the two DNA ends, which could be due
to the presence of sequences preferentially binding p6 (46).
This high binding is probably related to a requirement for
protein p6 in viral DNA replication (47) and for repression of
the early promoter C2 (23±25). Interestingly, binding to
internal regions F3, F4 and F5, where no role for p6 has ever
been described, is higher than to region F2, where p6 is
involved in the early±late transcriptional switch (26±28). In
summary, p6 binding along F29 DNA strongly supports an
architectural role, in agreement with other p6 features, such as
its abundance, lack of sequence speci®city and effects in
replication and transcription, which could be envisaged as
local outcomes of a more global role as a histone-like protein.
We also show that protein p6 binds with high preference to
viral with respect to plasmid DNA and that it is superhelicity
which provides this speci®city, as the level of negative
supercoiling of bacterial (plasmid and chromosomal) DNA is
presumably lower than that of non-covalently closed F29
DNA. In vivo, we have shown that when the negative
superhelicity of the plasmid is decreased by novobiocin,
protein p6 binding is signi®cantly increased in infected and
uninfected cells; on the other hand, binding was essentially
unchanged with nalidixic acid, which inhibits gyrase but does
not alter the topological state of the plasmid. We have
con®rmed these results in vitro by ¯uorescence quenching of
protein p6 with plasmids of different degrees of supercoiling,
the highest af®nity corresponding to the linearized, topologi-
cally unconstrained form. Therefore, protein p6 binding
increases when negative supercoiling is lowered, strongly
suggesting that, as shown in vitro (18), protein p6 restrains
positive supercoiling in vivo. Supercoiling-dependent DNA
binding is a smart strategy to prevent titration of a sequence-
non-speci®c protein such as p6 by bacterial DNA, with a much
higher mass than that of viral DNA.
In conclusion, we report the ®rst in vivo direct evidence of a
bacteriophage DNA architectural protein. We have demon-
strated that: (i) phage F29 protein p6 binds all along the F29
DNA; (ii) this binding is speci®c to viral DNA; (iii) p6 binding
depends on DNA superhelicity so that the speci®city could be
based on a lower negative superhelicity of viral DNA.
Together with all the previous evidence in vitro, we conclude
that protein p6 globally organizes and compacts the viral
genome, with local effects on replication and transcription.
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